Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Astellas Pharma AB

Closing information (x1000 EUR)

Closing information 2025/03 2024/03 2023/03
Turnover 4,578 Less Arrow 3,298 More Arrow 3,885
Financial expenses 17 Less Arrow 6 More Arrow 14
Earnings before taxes 98 Less Arrow 75 More Arrow 177
EBITDA 91 Less Arrow 51 More Arrow 191
Total assets 7,975 Less Arrow 6,177 Less Arrow 4,975
Current assets 7,975 Less Arrow 6,177 Less Arrow 4,975
Current liabilities 4,237 Less Arrow 2,689 Less Arrow 1,621
Equity capital 3,738 Less Arrow 3,488 Less Arrow 3,354
- share capital 23 Less Arrow 22 Equal arrow 22
Employees (average) 11 More Arrow 16 Equal arrow 16

Financial ratios

Fiscal year 2025/03 2024/03 2023/03
Solvency 46.9% More Arrow 56.5% More Arrow 67.4%
Turnover per employee 416 Less Arrow 206 More Arrow 243
Profit as a percentage of turnover 2.1% More Arrow 2.3% More Arrow 4.6%
Return on assets (ROA) 1.4% Less Arrow 1.3% More Arrow 3.8%
Current ratio 188.2% More Arrow 229.7% More Arrow 306.9%
Return on equity (ROE) 2.6% Less Arrow 2.2% More Arrow 5.3%
Change turnover 1,075 Less Arrow -503 More Arrow 235
Change turnover % 31% Less Arrow -13% More Arrow 6%
Chg. No. of employees -5 More Arrow 0 Less Arrow -2
Chg. No. of employees % -31% More Arrow 0% Less Arrow -11%

Total value of public sale

Fiscal year 2025/03 2024/03 2023/03
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.